Alpha Tau Medical Ltd(DRTS)

Biotechnology · Jerusalem, JM

$14.68-0.21 (-1.40%)

Delayed quote: Oct 6, 2026, 11:49 AM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T15:51:16.064Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:51:16.064Z.

Quote observation: 2026-10-06T15:49:59.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,326,128,381
Total debt · period ending 2026-06-30: 15,152,000
Cash · period ending 2026-06-30: 22,993,000
TTM free cash flow · period ending 2025-12-31: N/A

FMP input reference: d0cade57d6bc8828dc71ac364ddc44a4328d7c948fb2699a56d4eea8e3f6e5b7

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

DRTS EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

DRTS Competitors' EV/FCF Ratio

DRTS

Alpha Tau Medical Ltd

Current

Market Cap

$1.33B

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OMER

Omeros Corporation

vs DRTS

Market Cap

$1.35B

EV/FCF Ratio

N/A

TTM Avg

6.97x

3Y Avg

6.99x

5Y Avg

6.99x

KARD

Kardigan, Inc.

vs DRTS

Market Cap

$1.30B

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COAG

Hemab Therapeutics Holdings, Inc. Common Stock

vs DRTS

Market Cap

$1.37B

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORIC

ORIC Pharmaceuticals, Inc.

vs DRTS

Market Cap

$1.24B

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KLRA

Kailera Therapeutics, Inc.

vs DRTS

Market Cap

$1.41B

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INBX

Inhibrx Biosciences Inc.

vs DRTS

Market Cap

$1.41B

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRON

Cronos Group Inc.

vs DRTS

Market Cap

$1.23B

EV/FCF Ratio

15.32x

TTM Avg

580.30x

3Y Avg

501.54x

5Y Avg

501.54x

PNTG

The Pennant Group, Inc.

vs DRTS

Market Cap

$1.42B

EV/FCF Ratio

72.98x

TTM Avg

54.11x

3Y Avg

63.60x

5Y Avg

65.58x

OMDA

Omada Health

vs DRTS

Market Cap

$1.23B

EV/FCF Ratio

50.28x

TTM Avg

50.12x

3Y Avg

50.12x

5Y Avg

50.12x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Alpha Tau Medical Ltd (DRTS)	$1.33B	N/A	N/A	N/A	N/A
Omeros Corporation (OMER)vs ›	$1.35B	N/A	6.97x	6.99x	6.99x
Kardigan, Inc. (KARD)vs ›	$1.30B	N/A	N/A	N/A	N/A
Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs ›	$1.37B	N/A	N/A	N/A	N/A
ORIC Pharmaceuticals, Inc. (ORIC)vs ›	$1.24B	N/A	N/A	N/A	N/A
Kailera Therapeutics, Inc. (KLRA)vs ›	$1.41B	N/A	N/A	N/A	N/A
Inhibrx Biosciences Inc. (INBX)vs ›	$1.41B	N/A	N/A	N/A	N/A
Cronos Group Inc. (CRON)vs ›	$1.23B	15.32x	580.30x	501.54x	501.54x
The Pennant Group, Inc. (PNTG)vs ›	$1.42B	72.98x	54.11x	63.60x	65.58x
Omada Health (OMDA)vs ›	$1.23B	50.28x	50.12x	50.12x	50.12x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

DRTS EV/FCF Ratio Metrics

DRTS Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics